Viewing Study NCT00684593


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-04-13 @ 5:55 PM
Study NCT ID: NCT00684593
Status: COMPLETED
Last Update Posted: 2019-02-05
First Post: 2008-05-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-06-01
Start Date Type: ACTUAL
Primary Completion Date: 2007-10-01
Primary Completion Date Type: ACTUAL
Completion Date: 2007-10-01
Completion Date Type: ACTUAL
First Submit Date: 2008-05-22
First Submit QC Date: None
Study First Post Date: 2008-05-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-09-26
Results First Submit QC Date: None
Results First Post Date: 2014-10-06
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-01-17
Last Update Post Date: 2019-02-05
Last Update Post Date Type: ACTUAL